Literature DB >> 15793294

tPA receptors and the fibrinolytic response in multiple sclerosis lesions.

Djordje Gveric1, Blanca M Herrera, M Louise Cuzner.   

Abstract

Axonal damage in multiple sclerosis (MS) lesions is associated with failure of fibrinolysis because of the inhibition of the plasminogen activator system. Plasma membrane receptors for tissue plasminogen activator (tPA) and plasminogen concentrate proteolytic activity on the cell surface and provide protection from inhibitors that in turn may locally enhance the fibrinolytic response. Therefore, we have investigated expression of two of these receptors in MS lesions, annexin II tetramer (AIIt) and low-density lipoprotein receptor-related protein (LRP). In acute MS lesions both AIIt and LRP were immunolocalized on macrophages and astrocytes while LRP was additionally found on neuronal cells in cortical gray matter. Western blot analysis confirmed a significant increase in AIIt in MS lesions and in a proportion of normal-appearing white matter samples, with a highly significant correlation between annexin II levels and factors associated with impeded fibrinolysis, such as plasminogen activator inhibitor-1. Immunoblotting analysis of plasmin(ogen) revealed increased levels of lysine-plasminogen in samples expressing high AIIt protein levels. Our results suggest that limited availability of tPA in MS lesions because of formation of tPA-plasminogen activator inhibitor-1 complexes reduces capability of tPA receptors to generate plasmin, which further diminishes fibrinolytic capacity in active MS lesions and possibly leads to axonal damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793294      PMCID: PMC1602376          DOI: 10.1016/S0002-9440(10)62334-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

1.  Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.

Authors:  R P Czekay; T A Kuemmel; R A Orlando; M G Farquhar
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 2.  Annexin II: a mediator of the plasmin/plasminogen activator system.

Authors:  K A Hajjar; S Krishnan
Journal:  Trends Cardiovasc Med       Date:  1999-07       Impact factor: 6.677

3.  Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II.

Authors:  C Y Chung; J E Murphy-Ullrich; H P Erickson
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

4.  Annexin II and bleeding in acute promyelocytic leukemia.

Authors:  J S Menell; G M Cesarman; A T Jacovina; M A McLaughlin; E A Lev; K A Hajjar
Journal:  N Engl J Med       Date:  1999-04-01       Impact factor: 91.245

Review 5.  Fibrin-mediated plasminogen activation.

Authors:  W Nieuwenhuizen
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

6.  The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development.

Authors:  M Narita; G Bu; D M Holtzman; A L Schwartz
Journal:  J Neurochem       Date:  1997-02       Impact factor: 5.372

7.  Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques.

Authors:  H Li; J Newcombe; N P Groome; M L Cuzner
Journal:  Neuropathol Appl Neurobiol       Date:  1993-06       Impact factor: 8.090

8.  Expression of receptors for plasminogen activators on endothelial cell surface depends on their origin.

Authors:  H C Kwaan; J Wang; I Weiss
Journal:  J Thromb Haemost       Date:  2004-02       Impact factor: 5.824

9.  Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.

Authors:  K Akassoglou; K W Kombrinck; J L Degen; S Strickland
Journal:  J Cell Biol       Date:  2000-05-29       Impact factor: 10.539

10.  Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors.

Authors:  Djordje Gveric; Blanca Herrera; Axel Petzold; Daniel A Lawrence; M Louise Cuzner
Journal:  Brain       Date:  2003-06-04       Impact factor: 13.501

View more
  6 in total

1.  The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans.

Authors:  Maithili Sashindranath; Eunice Sales; Maria Daglas; Roxann Freeman; Andre L Samson; Elisa J Cops; Simone Beckham; Adam Galle; Catriona McLean; Cristina Morganti-Kossmann; Jeffrey V Rosenfeld; Rime Madani; Jean-Dominique Vassalli; Enming J Su; Daniel A Lawrence; Robert L Medcalf
Journal:  Brain       Date:  2012-07-20       Impact factor: 13.501

2.  Cardiovascular Dysfunction in Multiple Sclerosis.

Authors:  Raluca Ileana Mincu; Lucia Stefania Magda; Maria Florescu; Andreea Velcea; Sorina Mihaila; Diana Mihalcea; Bogdan O Popescu; Adela Chiru; Cristina Tiu; Mircea Cinteza; Dragos Vinereanu
Journal:  Maedica (Bucur)       Date:  2015-09

3.  Early responses to deep brain stimulation in depression are modulated by anti-inflammatory drugs.

Authors:  L Perez-Caballero; R Pérez-Egea; C Romero-Grimaldi; D Puigdemont; J Molet; J-R Caso; J-A Mico; V Pérez; J-C Leza; E Berrocoso
Journal:  Mol Psychiatry       Date:  2013-05-28       Impact factor: 15.992

4.  Production of IL-16 correlates with CD4+ Th1 inflammation and phosphorylation of axonal cytoskeleton in multiple sclerosis lesions.

Authors:  Dusanka S Skundric; Juan Cai; William W Cruikshank; Djordje Gveric
Journal:  J Neuroinflammation       Date:  2006-05-26       Impact factor: 8.322

Review 5.  Coagulation Pathways in Neurological Diseases: Multiple Sclerosis.

Authors:  Nicole Ziliotto; Francesco Bernardi; Dejan Jakimovski; Robert Zivadinov
Journal:  Front Neurol       Date:  2019-04-24       Impact factor: 4.003

6.  The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.

Authors:  Maja Zivković; Nada Starčević Čizmarević; Luca Lovrečić; Inge Klupka-Sarić; Aleksandra Stanković; Iva Gašparović; Polona Lavtar; Evica Dinčić; Ljiljana Stojković; Gorazd Rudolf; Saša Sega Jazbec; Olivio Perković; Osman Sinanović; Juraj Sepčić; Miljenko Kapović; Borut Peterlin; Smiljana Ristić
Journal:  Dis Markers       Date:  2014-04-16       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.